New FY 2022 Categorical Spending Data Are Now Available
NIH recently updated its annual categorical information with fiscal year (FY) 2022 actual spending data and estimates for FY 2023 and 2024. Available on the Research, Condition, and Disease Categorization (RCDC) page, you will find the annual support level for various research, condition, and disease categories. The data are based on grants, contracts, and other funding mechanisms used across NIH.
There were 215 public categories when RCDC information began being reported in 2008. Now in our fifteenth year, there are a total of 315 categories. The following new categories were added in FY 2022:
Cocaine
PASC (Post-Acute Se...
Source: NIH Extramural Nexus - April 4, 2023 Category: Research Authors: NIH Staff Tags: New Resources NIH budget RCDC Source Type: funding
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-330 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Avai...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 8, 2021 Category: Research Source Type: funding
Request for Information (RFI): Ovarian Anatomy Nomenclature Workshop Proposal at NICHD
Notice NOT-HD-21-015 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 16, 2021 Category: Research Source Type: funding
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-OD-21-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications to stimulate exploratory research relevant to the mission of the Food and Drug Administration (FDA) - Center for Tobacco Products (CTP) using existing (publicly available) biospecimens currently stored in repositories in the United States. This will include, but not be limited to, collections associated with the Population Assessment of Tobacco and Health (PATH) Study, the National Health and Nutrition Examination Survey (NHANES), the National Heart, Lung...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 10, 2021 Category: Research Source Type: funding
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-OD-19-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications to stimulate exploratory research relevant to the mission of the Food and Drug Administration (FDA) - Center for Tobacco Products (CTP) using existing (publicly available) biospecimen currently stored in repositories in the United States. Including, but not limited to, collections associated with the Population Assessment of Tobacco and Health (PATH) Study, the National Health and Nutrition Examination Survey (NHANES), the NHLBI Biologic Specimen and Data...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 8, 2019 Category: Research Source Type: funding
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-913 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Avai...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2018 Category: Research Source Type: funding
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional)
Funding Opportunity PA-18-839 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction, and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reprodu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional)
Funding Opportunity PA-18-838 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction, and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reprodu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding
The Early Detection Research Network: Biomarker Developmental Laboratories (U01)
Funding Opportunity Number: RFA-CA-16-009 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCFDA Number: 93.394Eligible Applicants State governmentsPublic and State controlled institutions of higher educationNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businessesSmall businessesOthers (see text ...
Source: Grants.gov - March 20, 2016 Category: Research Tags: Education Health Source Type: funding
DoD Ovarian Cancer Investigator-Initiated Research Award
Funding Opportunity Number: W81XWH-16-OCRP-IIRA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Aug 10, 2016Award Ceiling: Expected Number of Awards: 6Creation Date: Mar 16, 2016Funding Opportunity Description: The OCRP Investigator-Initiated ...
Source: Grants.gov - March 17, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Ovarian Cancer Clinical Development Award
Funding Opportunity Number: W81XWH-16-OCRP-CDA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Aug 10, 2016Award Ceiling: Expected Number of Awards: 3Creation Date: Mar 16, 2016Funding Opportunity Description: The OCRP Clinical Development Awa...
Source: Grants.gov - March 17, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Ovarian Cancer Pilot Award
Funding Opportunity Number: W81XWH-16-OCRP-PA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Aug 10, 2016Award Ceiling: Expected Number of Awards: 16Creation Date: Mar 16, 2016Funding Opportunity Description: The OCRP Pilot Award supports the...
Source: Grants.gov - March 17, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Ovarian Cancer Academy - Early-Career Investigator Award
Funding Opportunity Number: W81XWH-16-OCRP-OCA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Aug 10, 2016Award Ceiling: Expected Number of Awards: 2Creation Date: Mar 16, 2016Funding Opportunity Description: The OCRP Ovarian Cancer Academy, ...
Source: Grants.gov - March 17, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
The Early Detection Research Network: Biomarker Developmental Laboratories (U01)
Funding Opportunity RFA-CA-16-009 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit organ-specific applications for Biomarker Developmental Laboratories (BDLs), one of the four scientific units of the recently funded Early Detection Research Network (EDRN). The EDRN is a national infrastructure funded to discover, develop, and validate biomarkers for risk assessment, detection, and molecular diagnosis and prognosis of early cancer. BDLs are responsible for the discovery, development, characterization, and testing of new, or the refinement of existing...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 17, 2016 Category: Research Source Type: funding
Pregnancy Risk Assessment Monitoring System (PRAMS)
Funding Opportunity Number: RFA-DP-16-001 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.946Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsNative American tribal governments (Federally recognized)Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Nov 20, 2015Award Ceiling: $175,000Expected Number of Awards: 61Creation Date: Sep 20, 2015Funding Opportunity ...
Source: Grants.gov - September 21, 2015 Category: Research Tags: Health Source Type: funding
